334 related articles for article (PubMed ID: 26979597)
21. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.
Shimada M; Tsukada K; Kagawa N; Matsumoto Y
J Radiat Res; 2019 Nov; 60(6):719-728. PubMed ID: 31665364
[TBL] [Abstract][Full Text] [Related]
23. Variations in mesenchymal-epithelial transition-related transcription factors during reprogramming of somatic cells from different germ layers into iPSCs.
Lu X; Wang Y; Yan L; Wang L; Li W; Wang H
J Genet Genomics; 2016 Oct; 43(10):609-612. PubMed ID: 27756625
[No Abstract] [Full Text] [Related]
24. Making a Hematopoietic Stem Cell.
Daniel MG; Pereira CF; Lemischka IR; Moore KA
Trends Cell Biol; 2016 Mar; 26(3):202-214. PubMed ID: 26526106
[TBL] [Abstract][Full Text] [Related]
25. Dynamically reorganized chromatin is the key for the reprogramming of somatic cells to pluripotent cells.
Huang K; Zhang X; Shi J; Yao M; Lin J; Li J; Liu H; Li H; Shi G; Wang Z; Zhang B; Chen J; Pan G; Jiang C; Pei D; Yao H
Sci Rep; 2015 Dec; 5():17691. PubMed ID: 26639176
[TBL] [Abstract][Full Text] [Related]
26. Induced Pluripotent Stem Cells Reprogrammed with Three Inhibitors Show Accelerated Differentiation Potentials with High Levels of 2-Cell Stage Marker Expression.
Nishihara K; Shiga T; Nakamura E; Akiyama T; Sasaki T; Suzuki S; Ko MSH; Tada N; Okano H; Akamatsu W
Stem Cell Reports; 2019 Feb; 12(2):305-318. PubMed ID: 30713040
[TBL] [Abstract][Full Text] [Related]
27. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
[TBL] [Abstract][Full Text] [Related]
28. Role of circadian gene Clock during differentiation of mouse pluripotent stem cells.
Lu C; Yang Y; Zhao R; Hua B; Xu C; Yan Z; Sun N; Qian R
Protein Cell; 2016 Nov; 7(11):820-832. PubMed ID: 27664156
[TBL] [Abstract][Full Text] [Related]
29. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
[TBL] [Abstract][Full Text] [Related]
30. Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.
Kuno A; Nishimura K; Takahashi S
BMC Genomics; 2018 Jan; 19(1):9. PubMed ID: 29298685
[TBL] [Abstract][Full Text] [Related]
31. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
32. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells.
Batta K; Florkowska M; Kouskoff V; Lacaud G
Cell Rep; 2014 Dec; 9(5):1871-1884. PubMed ID: 25466247
[TBL] [Abstract][Full Text] [Related]
33. Reprogramming adult hematopoietic cells.
Kaneko S; Otsu M; Nakauchi H
Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
[TBL] [Abstract][Full Text] [Related]
34. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
[TBL] [Abstract][Full Text] [Related]
35. Adult stem and progenitor cells.
Geraerts M; Verfaillie CM
Adv Biochem Eng Biotechnol; 2009; 114():1-21. PubMed ID: 19373451
[TBL] [Abstract][Full Text] [Related]
36. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells.
Manian KV; Aalam SM; Bharathan SP; Srivastava A; Velayudhan SR
Cell Reprogram; 2015 Dec; 17(6):427-40. PubMed ID: 26562626
[TBL] [Abstract][Full Text] [Related]
37. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
38. Resolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq.
Guo L; Lin L; Wang X; Gao M; Cao S; Mai Y; Wu F; Kuang J; Liu H; Yang J; Chu S; Song H; Li D; Liu Y; Wu K; Liu J; Wang J; Pan G; Hutchins AP; Liu J; Pei D; Chen J
Mol Cell; 2019 Feb; 73(4):815-829.e7. PubMed ID: 30772174
[TBL] [Abstract][Full Text] [Related]
39. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
40. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
